fbpx

SCIENTIFIC ADVISORY BOARD

MEET THE BOARD

Medical and thought leaders from across the globe are coming together to guide the process and vet nominees for the Sanford Lorraine Cross Award. Along with Sanford Health, this visionary group of influencers is changing the face of medical care in their own work and will help set the drumbeat for worldwide innovation and future cures.

HOWARD BAILEY MD

BEVERLY DAVIDSON PhD

STEPHEN DEWHURST PhD

DANIEL H. GESCHWIND MD, PhD

MARILYN GLASSBERG CSETE MD, FACP, FCCP

CARLA GREENBAUM MD

CLAUDE MOORMAN, III MD

DAVID A. PEARCE PhD

SUSAN RHEINGOLD MD

DAVID SINCLAIR PhD

HOWARD BAILEY
MD

University of Wisconsin, Associate Dean for Oncology at the University of Wisconsin School of Medicine and Public Health; Director of the University of Wisconsin Carbone Cancer Center; Professor of Medicine

  • An accomplished cancer physician with decades of experience in anti-cancer drug development and building regional and national research networks.

FULL BIO

BEVERLY DAVIDSON
PhD

Children’s Hospital of Philadelphia, Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics and Chief Scientific Strategy Officer

FULL BIO

STEPHEN DEWHURST
PhD

University of Rochester (UR) School of Medicine and Dentistry, Vice Dean for Research and Chair of Microbiology and Immunology

  • Laboratory studies both HIV and influenza viruses
  • Current NIH student section member and past member of the NIH Recombinant Advisory Committee
  • Directs or co-directors several specific training programs at UR including the unique Rochester Postdoctoral Partnership, which supports the academic career development of deaf and hard of hearing postdoctoral fellows
  • Oversees the UR’s Stem Cell cGMP Facility, which produces cell-based products for the first in-human clinical trials

FULL BIO

DANIEL H. GESCHWIND
MD, PhD

University of California Los Angeles (UCLA), Gordon and Virginia MacDonald Distinguished Professor of Neurology, Psychiatry and Human Genetics; Board Certified Neurologist; Semel Institute at UCLA, Director, Neurogenetics Program in the Department of Neurology and the Center for Autism Research and Treatment (CART); UCLA Health System and David Geffen School of Medicine, Senior Associate Dean and Associate Vice Chancellor of Precision Medicine

  • Conducts research in neurogenetics: autism and language; focal neurodegenerative syndromes; and the structural/molecular basis of human cognitive specializations
  • Has published over 500 papers and serves on the editorial boards of Biological Psychiatry; Cell; Current Opinion in Genetics & Development; Human Molecular Genetics; Neurobiology of Disease; Neuron and Science
  • Served on multiple scientific advisory boards including the NIH Council of Councils, the NIH Mental Health Advisory Council and the Allen Institute
  • Among the highest cited scientists in the field of neuroscience and genetics and is an elected Member of the American Association of Physicians and the National Academy of Medicine

FULL BIO

MARILYN GLASSBERG CSETE
MD, FACP, FCCP

University of Arizona College of Medicine, Professor of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice-Chair of Diversity and Inclusion; Senior Director, Clinical Research Strategy and Growth; Banner-University Medical Center Phoenix, Physician Executive Director

  • Expert in rare lung diseases
  • Studies and treats interstitial lung disease, notably pulmonary fibrosis and lymphangioleiomyomatosis (LAM), a rare disease affecting young women
  • University of Miami Health System-UHealth one of 15 sites to open a clinic for patients with LAM
  • Awarded the National Library of Medicine Award, Dines Named Visiting Professorship at Mayo Clinic Rochester for her seminal studies in cell-based therapies in chronic lung disease

FULL BIO

CARLA GREENBAUM
MD

Benaroya Research Institute, Director, Diabetes Research Program; Director, Clinical Research Center

  • A clinical investigator focusing on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function
  • Expertise includes clinical trial design and implementation; evaluation of biomarkers for disease course; and response to therapy
  • Currently serves as Chair of Type 1 Diabetes TrialNet

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

CARLA GREENBAUM
MD

Benaroya Research Institute, Director, Diabetes Research Program; Director, Clinical Research Center

  • A clinical investigator focusing on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function
  • Expertise includes clinical trial design and implementation; evaluation of biomarkers for disease course; and response to therapy
  • Currently serves as Chair of Type 1 Diabetes TrialNet

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

MARILYN GLASSBERG CSETE
MD, FACP, FCCP

University of Arizona College of Medicine, Professor of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice-Chair of Diversity and Inclusion; Senior Director, Clinical Research Strategy and Growth; Banner-University Medical Center Phoenix, Physician Executive Director

  • Expert in rare lung diseases
  • Studies and treats interstitial lung disease, notably pulmonary fibrosis and lymphangioleiomyomatosis (LAM), a rare disease affecting young women
  • University of Miami Health System-UHealth one of 15 sites to open a clinic for patients with LAM
  • Awarded the National Library of Medicine Award, Dines Named Visiting Professorship at Mayo Clinic Rochester for her seminal studies in cell-based therapies in chronic lung disease

FULL BIO

CARLA GREENBAUM
MD

Benaroya Research Institute, Director, Diabetes Research Program; Director, Clinical Research Center

  • A clinical investigator focusing on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function
  • Expertise includes clinical trial design and implementation; evaluation of biomarkers for disease course; and response to therapy
  • Currently serves as Chair of Type 1 Diabetes TrialNet

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

DANIEL H. GESCHWIND
MD, PhD

University of California Los Angeles (UCLA), Gordon and Virginia MacDonald Distinguished Professor of Neurology, Psychiatry and Human Genetics; Board Certified Neurologist; Semel Institute at UCLA, Director, Neurogenetics Program in the Department of Neurology and the Center for Autism Research and Treatment (CART); UCLA Health System and David Geffen School of Medicine, Senior Associate Dean and Associate Vice Chancellor of Precision Medicine

  • Conducts research in neurogenetics: autism and language; focal neurodegenerative syndromes; and the structural/molecular basis of human cognitive specializations
  • Has published over 500 papers and serves on the editorial boards of Biological Psychiatry; Cell; Current Opinion in Genetics & Development; Human Molecular Genetics; Neurobiology of Disease; Neuron and Science
  • Served on multiple scientific advisory boards including the NIH Council of Councils, the NIH Mental Health Advisory Council and the Allen Institute
  • Among the highest cited scientists in the field of neuroscience and genetics and is an elected Member of the American Association of Physicians and the National Academy of Medicine

FULL BIO

MARILYN GLASSBERG CSETE
MD, FACP, FCCP

University of Arizona College of Medicine, Professor of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice-Chair of Diversity and Inclusion; Senior Director, Clinical Research Strategy and Growth; Banner-University Medical Center Phoenix, Physician Executive Director

  • Expert in rare lung diseases
  • Studies and treats interstitial lung disease, notably pulmonary fibrosis and lymphangioleiomyomatosis (LAM), a rare disease affecting young women
  • University of Miami Health System-UHealth one of 15 sites to open a clinic for patients with LAM
  • Awarded the National Library of Medicine Award, Dines Named Visiting Professorship at Mayo Clinic Rochester for her seminal studies in cell-based therapies in chronic lung disease

FULL BIO

CARLA GREENBAUM
MD

Benaroya Research Institute, Director, Diabetes Research Program; Director, Clinical Research Center

  • A clinical investigator focusing on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function
  • Expertise includes clinical trial design and implementation; evaluation of biomarkers for disease course; and response to therapy
  • Currently serves as Chair of Type 1 Diabetes TrialNet

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

STEPHEN DEWHURST
PhD

University of Rochester (UR) School of Medicine and Dentistry, Vice Dean for Research and Chair of Microbiology and Immunology

  • Laboratory studies both HIV and influenza viruses
  • Current NIH student section member and past member of the NIH Recombinant Advisory Committee
  • Directs or co-directors several specific training programs at UR including the unique Rochester Postdoctoral Partnership, which supports the academic career development of deaf and hard of hearing postdoctoral fellows
  • Oversees the UR’s Stem Cell cGMP Facility, which produces cell-based products for the first in-human clinical trials

FULL BIO

DANIEL H. GESCHWIND
MD, PhD

University of California Los Angeles (UCLA), Gordon and Virginia MacDonald Distinguished Professor of Neurology, Psychiatry and Human Genetics; Board Certified Neurologist; Semel Institute at UCLA, Director, Neurogenetics Program in the Department of Neurology and the Center for Autism Research and Treatment (CART); UCLA Health System and David Geffen School of Medicine, Senior Associate Dean and Associate Vice Chancellor of Precision Medicine

  • Conducts research in neurogenetics: autism and language; focal neurodegenerative syndromes; and the structural/molecular basis of human cognitive specializations
  • Has published over 500 papers and serves on the editorial boards of Biological Psychiatry; Cell; Current Opinion in Genetics & Development; Human Molecular Genetics; Neurobiology of Disease; Neuron and Science
  • Served on multiple scientific advisory boards including the NIH Council of Councils, the NIH Mental Health Advisory Council and the Allen Institute
  • Among the highest cited scientists in the field of neuroscience and genetics and is an elected Member of the American Association of Physicians and the National Academy of Medicine

FULL BIO

MARILYN GLASSBERG CSETE
MD, FACP, FCCP

University of Arizona College of Medicine, Professor of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice-Chair of Diversity and Inclusion; Senior Director, Clinical Research Strategy and Growth; Banner-University Medical Center Phoenix, Physician Executive Director

  • Expert in rare lung diseases
  • Studies and treats interstitial lung disease, notably pulmonary fibrosis and lymphangioleiomyomatosis (LAM), a rare disease affecting young women
  • University of Miami Health System-UHealth one of 15 sites to open a clinic for patients with LAM
  • Awarded the National Library of Medicine Award, Dines Named Visiting Professorship at Mayo Clinic Rochester for her seminal studies in cell-based therapies in chronic lung disease

FULL BIO

CARLA GREENBAUM
MD

Benaroya Research Institute, Director, Diabetes Research Program; Director, Clinical Research Center

  • A clinical investigator focusing on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function
  • Expertise includes clinical trial design and implementation; evaluation of biomarkers for disease course; and response to therapy
  • Currently serves as Chair of Type 1 Diabetes TrialNet

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO

BEVERLY DAVIDSON
PhD

Children’s Hospital of Philadelphia, Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics and Chief Scientific Strategy Officer

FULL BIO

STEPHEN DEWHURST
PhD

University of Rochester (UR) School of Medicine and Dentistry, Vice Dean for Research and Chair of Microbiology and Immunology

  • Laboratory studies both HIV and influenza viruses
  • Current NIH student section member and past member of the NIH Recombinant Advisory Committee
  • Directs or co-directors several specific training programs at UR including the unique Rochester Postdoctoral Partnership, which supports the academic career development of deaf and hard of hearing postdoctoral fellows
  • Oversees the UR’s Stem Cell cGMP Facility, which produces cell-based products for the first in-human clinical trials

FULL BIO

DANIEL H. GESCHWIND
MD, PhD

University of California Los Angeles (UCLA), Gordon and Virginia MacDonald Distinguished Professor of Neurology, Psychiatry and Human Genetics; Board Certified Neurologist; Semel Institute at UCLA, Director, Neurogenetics Program in the Department of Neurology and the Center for Autism Research and Treatment (CART); UCLA Health System and David Geffen School of Medicine, Senior Associate Dean and Associate Vice Chancellor of Precision Medicine

  • Conducts research in neurogenetics: autism and language; focal neurodegenerative syndromes; and the structural/molecular basis of human cognitive specializations
  • Has published over 500 papers and serves on the editorial boards of Biological Psychiatry; Cell; Current Opinion in Genetics & Development; Human Molecular Genetics; Neurobiology of Disease; Neuron and Science
  • Served on multiple scientific advisory boards including the NIH Council of Councils, the NIH Mental Health Advisory Council and the Allen Institute
  • Among the highest cited scientists in the field of neuroscience and genetics and is an elected Member of the American Association of Physicians and the National Academy of Medicine

FULL BIO

MARILYN GLASSBERG CSETE
MD, FACP, FCCP

University of Arizona College of Medicine, Professor of Medicine; Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice-Chair of Diversity and Inclusion; Senior Director, Clinical Research Strategy and Growth; Banner-University Medical Center Phoenix, Physician Executive Director

  • Expert in rare lung diseases
  • Studies and treats interstitial lung disease, notably pulmonary fibrosis and lymphangioleiomyomatosis (LAM), a rare disease affecting young women
  • University of Miami Health System-UHealth one of 15 sites to open a clinic for patients with LAM
  • Awarded the National Library of Medicine Award, Dines Named Visiting Professorship at Mayo Clinic Rochester for her seminal studies in cell-based therapies in chronic lung disease

FULL BIO

CARLA GREENBAUM
MD

Benaroya Research Institute, Director, Diabetes Research Program; Director, Clinical Research Center

  • A clinical investigator focusing on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune-mediated beta cell function
  • Expertise includes clinical trial design and implementation; evaluation of biomarkers for disease course; and response to therapy
  • Currently serves as Chair of Type 1 Diabetes TrialNet

FULL BIO

CATHERINE HAJEK
MD

Sanford Health, Medical Director, Sanford Imagenetics

  • Leads the development and clinical implementation of Sanford Health’s preemptive genetic screening program
  • Academic Assistant Professor, University of South Dakota, Sanford School of Medicine
  • Research focus is in polygenic risk scores and health and economic outcomes related to preemptive genetic screening programs

FULL BIO

CLAUDE MOORMAN, III
MD

Atrium Health, President of Musculoskeletal Institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery

  • Previously the executive director of the James R. Urbaniak Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics
  • Spent more than two decades providing medical care to NFL, collegiate and high school athletic teams
  • Founded the sports medicine program at the University of Maryland

FULL BIO

DAVID A. PEARCE
PhD

Executive Vice President of Innovation and Research, Sanford Health

  • Oversees the development of research programs across Sanford’s nine-state footprint, including more than 450 researchers, eight research centers and more than 300 ongoing clinical trials
  • Head of the leading lab in Juvenile Batten disease research
  • Research has led to the first clinical trial for Juvenile Batten disease
  • Oversees a national registry for rare diseases known as the Coordination of Rare Diseases at Sanford (CoRDS)
  • Organized rare disease workshops for the National Institute for Neurological Disorders and Stroke (NINDS) arm of the National Institutes of Health (NIH)
  • Member of the executive committee for the International Rare Diseases Research Consortium (IRDiRC)

FULL BIO

SUSAN RHEINGOLD
MD

Children’s Hospital of Pennsylvania (CHOP), Medical Director of Oncology Outpatient Clinic; Attending Physician with the Cancer Center; Perelman School of Medicine, Professor of Pediatrics

  • Expertise in the diagnosis, treatment and biology of acute lymphocytic leukemia (ALL) and clinical trials for pediatric and young adult patients with relapsed ALL
  • Serves on the Children’s Oncology Group’s Relapsed ALL Committee and Infant ALL Committee and is Vice-chair of AALL1732
  • Member of the Cellular Immunotherapy team at CHOP

FULL BIO

DAVID SINCLAIR
PhD

Harvard Medical School, Professor, Department of Genetics; Co-Director of Paul F. Glenn Center for Biology of Aging Research

  • Research has focused primarily on understanding the role of sirtuins in disease and aging
  • Associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration and cancer
  • New York Times bestselling author for Lifespan (2019), has published over 200 scientific papers, is a co-inventor on more than 50 patents and has co-founded a dozen biotechnology companies in the areas of aging, vaccines, diabetes, fertility, cancer and biodefense

FULL BIO